Literature DB >> 8181859

Expression of uPA and its receptor by both neoplastic and stromal cells during xenograft invasion.

J Rømer1, C Pyke, L R Lund, J Eriksen, P Kristensen, E Rønne, G Høyer-Hansen, K Danø, N Brünner.   

Abstract

Recent studies have shown that molecules involved in generation and regulation of extracellular proteolytic activity are often expressed by non-malignant stromal cells during human cancer invasion. We have studied the expression of the urokinase-type plasminogen activator and the urokinase-type plasminogen activator cell-surface receptor in xenografts of human MDA-MB-231 mammary carcinoma cells growing invasively in nude mice. Northern analysis showed the presence of both human and mouse urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor mRNA in tumor extracts. By in situ hybridization, mRNA for human urokinase-type plasminogen activator and its receptor was detected in virtually all the cancer cells, while mouse urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor mRNA was expressed by tumor-infiltrating fibroblast-like and macrophage-like cells. In invasive areas the cells expressing the 2 murine mRNAs were either the same or located immediately adjacent to each other. This model system has several advantages for studies of the mechanism by which cancer cells induce or recruit stromal cells to produce molecules involved in proteolysis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8181859     DOI: 10.1002/ijc.2910570419

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  12 in total

1.  Regulation of tissue-degrading factors and in vitro invasiveness in progression of breast cancer cells.

Authors:  A H Ree; K Bjørnland; N Brünner; H T Johansen; K B Pedersen; A O Aasen; O Fodstad
Journal:  Clin Exp Metastasis       Date:  1998-04       Impact factor: 5.150

2.  The non-phagocytic route of collagen uptake: a distinct degradation pathway.

Authors:  Daniel H Madsen; Signe Ingvarsen; Henrik J Jürgensen; Maria C Melander; Lars Kjøller; Amanda Moyer; Christian Honoré; Charlotte A Madsen; Peter Garred; Sven Burgdorf; Thomas H Bugge; Niels Behrendt; Lars H Engelholm
Journal:  J Biol Chem       Date:  2011-06-07       Impact factor: 5.157

3.  Microarray and proteomics analyses of human intestinal epithelial cells treated with the Aeromonas hydrophila cytotoxic enterotoxin.

Authors:  C L Galindo; A A Fadl; Jian Sha; L Pillai; C Gutierrez; A K Chopra
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

4.  Cellular localisation by in situ hybridisation of cathepsin D, stromelysin 3, and urokinase plasminogen activator RNAs in breast cancer.

Authors:  C Escot; Y Zhao; C Puech; H Rochefort
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

5.  Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness.

Authors:  C Holst-Hansen; B Johannessen; G Høyer-Hansen; J Rømer; V Ellis; N Brünner
Journal:  Clin Exp Metastasis       Date:  1996-05       Impact factor: 5.150

6.  Expression of c-ets-1 mRNA is associated with an invasive, EMT-derived phenotype in breast carcinoma cell lines.

Authors:  C Gilles; M Polette; P Birembaut; N Brünner; E W Thompson
Journal:  Clin Exp Metastasis       Date:  1997-09       Impact factor: 5.150

Review 7.  Urokinase plasminogen activator as an anti-metastasis target: inhibitor design principles, recent amiloride derivatives, and issues with human/mouse species selectivity.

Authors:  Nehad S El Salamouni; Benjamin J Buckley; Marie Ranson; Michael J Kelso; Haibo Yu
Journal:  Biophys Rev       Date:  2022-01-06

Review 8.  The urokinase receptor (u-PAR)--a link between tumor cell dormancy and minimal residual disease in bone marrow?

Authors:  Heike Allgayer; Julio A Aguirre-Ghiso
Journal:  APMIS       Date:  2008 Jul-Aug       Impact factor: 3.205

9.  Regulation of u-PAR gene expression by H2A.Z is modulated by the MEK-ERK/AP-1 pathway.

Authors:  Santosh Chauhan; Douglas D Boyd
Journal:  Nucleic Acids Res       Date:  2011-09-21       Impact factor: 16.971

10.  Plasminogen binding and activation at the breast cancer cell surface: the integral role of urokinase activity.

Authors:  Gillian E Stillfried; Darren N Saunders; Marie Ranson
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.